UNAIDS | 2016–2021 Strategy
Accessed: 20.11.2019
Amsterdam, the Netherlands, 23 July 2018
Meeting Report
PLOS ONE | https://doi.org/10.1371/journal.pone.0192765 February 23, 2018
Recommended actions at international and national levels
A Cost-Efficiency Analysis for the Kyrgyz Republi
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...rmaceutical products, including product pricing, the regulatory environment and patent status, which together shape the national hepatitis response in different settings. It highlights key areas for action by ministries of health and other government decision-makers, pharmaceutical manufacturers and technical partners.
more